CGON 10-Q: SEC filing
CG Oncology, Inc.
Filed with the SEC on · accession 0001991792-26-000012
CGON filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. CG Oncology, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Arthur Kuan. The stock moved +11.9% by the first close after the filing.
Summary of the filing
CG Oncology, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Arthur Kuan. The certification attests to the accuracy of the financial statements and the effectiveness of disclosure controls and internal control over financial reporting.
Key details
How CGON stock reacted
Close before
$64.80
Nov 5, 2026
First close after
+11.85%
$72.48
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CGON, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CGON?
Click hereFrequently asked questions
What did CGON file with the SEC on Nov 6, 2026?
CGON filed a 10-Q (SEC filing). CG Oncology, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Arthur Kuan. The certification attests to the accuracy of the financial statements and the effectiveness of disclosure controls and internal control over financial reporting.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CGON stock react to this filing?
CGON closed at $64.80 before the filing and $72.48 on Nov 6, 2026 (+11.85%).
Other CGON SEC filings
- 8-K · SEC filingNov 6, 2026
- 424B5 · Secondary offeringAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Secondary offeringAug 6, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Board changeJun 8, 2026
- 8-K · Executive departureMay 26, 2026
- 10-Q · SEC filingMay 8, 2026
- 8-K · SEC filingMay 8, 2026
- DEF 14A · Board changeApr 24, 2026
Get alerts when CGON files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days